Heidi Rehm
banner
heidirehm.bsky.social
Heidi Rehm
@heidirehm.bsky.social
Genomic medicine researcher; chief genomics officer at MGH; clinical lab director at @broadinstitute
Looking forward to another great AGBT-Precision Health meeting in San Diego Sept 8-10. Abstracts due June 30th. Hope to see you there! We'll have an increased focus on rare disease and AI in genomics this year. #AGBTPH25 www.agbtprecisionhealth.org
HOME | AGBT Precision Health
www.agbtprecisionhealth.org
June 19, 2025 at 6:55 PM
Reposted by Heidi Rehm
13th Plenary will be held from 6 to 10 October 2025 in Uppsala, Sweden. The first two days will feature talks and discussions on genomic and health data sharing from global perspectives.

View our full speaker line up: broadinstitute.swoogo.com/ga4gh13plena...
Agenda
Agenda
broadinstitute.swoogo.com
May 29, 2025 at 2:14 PM
Our recent paper is out: Distinct rates of VUS reclassification are observed when subclassifying VUS by evidence level buff.ly/Z0DcO9Q If you don't have access, our preprint is here buff.ly/z8UvVtY This paper emphasizes the critical benefit of VUS subclassification for physicians and patients.
April 13, 2025 at 10:46 AM
We are excited to announce a call for papers for a special issue of Genome Medicine genomemedicine.biomedcentral.com on "Clinical interpretation of genome variation". The submission deadline is Dec 18, 2025. More info here: go.sn.pub/gskvsk.
Call for papers - Clinical interpretation of genome variation: volume II
go.sn.pub
March 28, 2025 at 10:21 PM
Reposted by Heidi Rehm
New preprint! We worked with @msftresearch.bsky.social and @broadinstitute.org to see whether large language models (LLMs) can be useful to variant scientists in deciding whether genetic variants seen in a patient are responsible for their disease. tl;dr yes they can: www.biorxiv.org/content/10.1...
Evidence Aggregator: AI reasoning applied to rare disease diagnostics
Retrieving, reviewing, and synthesizing technical information can be time-consuming and challenging, particularly when requiring specialized expertise, as is the case of variant assessment for rare di...
www.biorxiv.org
March 15, 2025 at 2:44 AM
Reposted by Heidi Rehm
Join us for this must-attend conference! 🌟 Explore discussions on #variantinterpretation guidelines, tools, variant effects, and more. Don’t miss insights from our stellar lineup of speakers, details here: bit.ly/4gt4EB6 @deciphergenomics.bsky.social @heidirehm.bsky.social @ee-reh-neh.bsky.social
Registration is now open for our Curating the Clinical Genome Conference! #CCG2025

🗓️Dates: 11 - 13 June 2025

If you are interested in shaping best practices for the clinical use of #GenomicsData, then this is the conference for you! 🧬

🗣️ Keynote: @heidirehm.bsky.social

📎Info: bit.ly/4gt4EB6
January 9, 2025 at 11:05 AM
Reposted by Heidi Rehm
The second data release from the GREGoR Consortium is now available on AnVIL for controlled access by the broader scientific community! 🧬

Learn more here:
anvilproject.org/news/2024/11...

#DataSharing #Genomics #Collaboration
Data Release - GREGoR Consortium - AnVIL Portal
anvilproject.org
December 12, 2024 at 1:24 AM
Reposted by Heidi Rehm
I am excited to present STRchive.org v2!

A resource for tandem repeats associated with Mendelian disease. We have resigned the website, added new loci, streamlined our data for easier reuse, added more detailed citations, presented population frequency data and more!
STRchive
An archive of STRs associated with human diseases
STRchive.org
December 12, 2024 at 8:58 PM
We are delighted to announce this year's call for applications for the NHGRI-funded MGB T32 Postdoctoral Training Program in Precision and Genomic Medicine https://buff.ly/414Xajk Please RT or share w/ those who may be interested.
November 27, 2024 at 3:10 PM
We are delighted to announce this year's call for applications for the NHGRI-funded MGB T32 Postdoctoral Training Program in Precision and Genomic Medicine https://buff.ly/414Xajk Please share w/ those who may be interested.
November 27, 2024 at 12:58 PM
I know many of you have been awaiting us launching transcript expression data in gnomAD. We were waiting for the GTEx v10 release which is now out so we are finally able to launch this. Enjoy!!
Proportion expressed across transcripts (pext), using GTEx v10, is now available on #gnomAD v4!
November 22, 2024 at 2:44 PM
Just started using Buffer to simultaneously post on @bsky.app, LinkedIn,‬ and X/Twitter as I make my gradual shift away from the toxic and biased world of X....
November 14, 2024 at 1:39 PM
Forthcoming guidance will recommend labs report VUS subclasses. We share experience of 4 labs including rates of reclassification of VUS subclasses. By highlighting VUS-high and downplaying VUS-low, this will be game-changing for dx genetic testing.
Distinct rates of VUS reclassification are observed when subclassifying VUS by evidence level
Purpose: Genetic testing commonly yields a plethora of variants of uncertain significance (VUS) that can lead to ongoing uncertainty for patients and their caregivers. While all VUS hold uncertainty,…
buff.ly
November 14, 2024 at 1:37 PM
Our ACMG WG will give guidance on when labs should and should not report VUS, including the use of VUS subclasses coming in the next Sequence Variant Classification guidelines. Please share your opinion on VUS reporting through our <10 min survey forms.gle/niNoAwfQmbWn...
ACMG Working Group Survey on VUS Reporting
The ACMG/AMP/CAP/ClinGen SVC v4.0 standards for sequence variant classification will soon be released and provide an easy framework for subclassifying VUS by likelihood of pathogenicity. Another worki...
forms.gle
June 28, 2024 at 11:07 AM